Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin.
D000287:Administration, Topical; D004121:Dimethyl Sulfoxide / Q000008:administration & dosage*; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012883:Skin Ulcer / Q000139:chemically induced / Q000517:prevention & control*
D004317:Doxorubicin; D004121:Dimethyl Sulfoxide